Direkt zum Inhalt
Merck

[Blood test for malignant lymphoma].

Nihon rinsho. Japanese journal of clinical medicine (2014-04-15)
Tsutomu Kobayashi, Junya Kuroda, Masafumi Taniwaki
ZUSAMMENFASSUNG

Malignant lymphoma is a neoplastic disease that develops in the lymph system, which consists of various different subtypes. In addition, the differential diagnosis of malignant lymphoma includes infections, autoimmune diseases, allergic diseases, endocrine disorders, and so on. Therefore accurate diagnosis is very important to decide therapeutic strategy. Blood test is the most common examination in clinical practice and used extensively for evaluating etiology, pathology, disease state, efficacy of treatment and disease prognosis of lymphoma. We are required to understand the characteristics of blood examinations correctly and use them appropriately in daily medical practice. Here, we introduce some blood examinations used for treatment of lymphoma.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
L-Milch-Dehydrogenase aus Kaninchenmuskel, Type XI, lyophilized powder, 600-1,200 units/mg protein
Sigma-Aldrich
L-Milch-Dehydrogenase aus Rinderherz, 1000 units/mL
Sigma-Aldrich
L-Milch-Dehydrogenase aus Kaninchenmuskel, Type II, ammonium sulfate suspension, 800-1,200 units/mg protein
Sigma-Aldrich
L-Milch-Dehydrogenase aus Rinderherz, Type III, ammonium sulfate suspension, ≥500 units/mg protein
Sigma-Aldrich
L-Milch-Dehydrogenase aus Rinderherz, Type XVII, buffered aqueous glycerol solution, ≥400 units/mg protein
Sigma-Aldrich
L-Lactat-Dehydrogenase, rekombinant aus E. coli, ≥90 U/mg
Sigma-Aldrich
L-Milch-Dehydrogenase aus Schweineherz, ammonium sulfate suspension, ≥200 units/mg protein
Sigma-Aldrich
L-Milch-Dehydrogenase aus Rindermuskel, Type X, ammonium sulfate suspension, ≥600 units/mg protein